Evidence map›Paper›PMID 22271652›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Phenotypic analysis of pneumococcal polysaccharide-specific B cells.

Noor Khaskhely, Jason Mosakowski, Rebecca S Thompson, Sadik Khuder, S Louise Smithson, M A Julie Westerink

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03039491 (Immune Response to Pneumococcal Vaccination in Aging HIV Positive Individuals), which is not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03039491 early_phase1completednot on this mapstarted 2015, after this paper: background citation

Immune Response to Pneumococcal Vaccination in Aging HIV Positive Individuals

TypeinterventionalSponsorMedical University of South CarolinaRan2015 to 2020Enrolled160ConditionsHIV Lipodystrophy, AgingArmsPneumococcal polysaccharide vaccine 23 valent, 13 valent conjugated pneumococcal vaccine
3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. B-1 lymphocytes in mice and nonhuman primates.Annals of the New York Academy of Sciences · 2015
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Noor KhaskhelyDepartment of Medicine, University of Toledo, Toledo, OH 43614, USA.
Jason Mosakowski
Rebecca S Thompson
Sadik Khuder
S Louise Smithson
M A Julie Westerink

Funding

Elderly Immune Response to Pneumococcal PolysaccharideR01AG015978 · NIA · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI WESTERINK, M.A. JULIA · 2000 to 2010
$2.4M
Immune Response to Pneumococcal Vaccination in HIV Infected AdultsR01AI081558 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI WESTERINK, M.A. JULIA · 2010 to 2013
$1.5M
NIAID NIH HHS R01 AI081558NIA NIH HHS R01 AG015978NIA NIH HHS R01AG015978PHS HHS R01A081558
6 · The paper itself

Abstract

The phenotype of B cells responsible for the production of anti-pneumococcal polysaccharide Ab has been unclear. Although individuals that respond poorly to the 23-valent pneumococcal polysaccharide (PPS) vaccine, Pneumovax, such as children <2 y, the asplenic, and a subset of common variable immunodeficiency patients, are profoundly deficient or lack IgM memory cells (CD27(+)IgM(+)), they are also deficient in the switched memory (CD27(+)IgM(-)) compartment. Direct characterization of PPS-specific B cells has not been performed. In this study, we labeled PPS14 and PPS23F with fluorescent markers. Fluorescently labeled PPS were used in FACSAria flow cytometry to characterize the phenotype of PPS-specific B cells obtained from 18 young adults pre- and postimmunization with Pneumovax. The labeled PPS were capable of inhibiting binding of Ab to the native PPS. Similarly, the native PPS were able to inhibit binding of PPS-specific B cells in a flow cytometric assay demonstrating specificity and functionality. Phenotypic analysis of unselected B cells, pre- and postimmunization, demonstrated a predominance of naive CD27(-)IgM(+) cells accounting for 61.5% of B cells. Likewise, the PPS-specific B cells obtained preimmunization consisted primarily of naive, CD27(-) B cells, 55.4-63.8%. In contrast, the PPS-specific B cells obtained postimmunization were predominantly IgM memory cells displaying the CD27(+)IgM(+), 54.2% for PPS14 and 66% for PPS23F, significantly higher than both unselected B cells and PPS-specific B cells. There was no significant difference in switched memory B cell populations (CD27(+)IgM(-)) between groups. These results suggest a dominant role of IgM memory cells in the immune response to pneumococcal polysaccharides.

Indexed as

AdolescentAdultAnimalsBacterial CapsulesBinding, CompetitiveBinding Sites, AntibodyB-Lymphocyte SubsetsEpitopes, B-LymphocyteHumansHybridomasImmunoglobulin AImmunoglobulin GImmunoglobulin MImmunologic MemoryImmunophenotypingMice23-valent pneumococcal capsular polysaccharide vaccineEpitopes, B-LymphocyteImmunoglobulin AImmunoglobulin GImmunoglobulin Mpneumococcal polysaccharide, type 14Pneumococcal Vaccines

Identifiers

PMID22271652
PMCPMC3288481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.